Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
co-careldopa 12,5 mg + 50 mg tablet | Is a | False | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some | |
carbidopa 50 mg + levodopa 200 mg tablet med modificeret udløsning | Is a | False | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some | |
carbidopa 10 mg + levodopa 100 mg tablet | Is a | False | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some | |
carbidopa 25 mg +levodopa 100 mg tablet | Is a | False | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some | |
carbidopa25 mg + levodopa 250 mg tablet | Is a | False | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some | |
carbidopa 25 mg + levodopa 100 mg tablet med modificeret udløsning | Is a | False | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some | |
carbidopa 10 mg + levodopa 100 mg oralt opløselig tablet | Is a | False | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some | |
carbidopa 25 mg + levodopa 100 mg oralt opløselig tablet | Is a | False | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some | |
carbidopa 25 mg + levodopa 250 mg oralt opløselig tablet | Is a | False | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some | |
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each prolonged-release oral tablet | Is a | False | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some | |
Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet | Is a | False | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some | |
Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form) | Is a | True | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some | |
Product containing only carbidopa and levodopa in oral dose form (medicinal product form) | Is a | True | Product containing carbidopa and levodopa in oral dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets